Katarakt ameliyatı geçiren hastalarda SARS-COV-2 enfeksiyonunun yüksek prevalansı

Yıl 2024, Cilt: 16 Sayı: 3, 86 - 90, 23.12.2024

Şerife Gülhan Konuk , Raşit Kılıç , Fatih Kaya , Alper Güneş

Öz

Anahtar Kelimeler

COVID-19, Oftalmoloji, Katarakt ameliyatı, SARS-CoV2, Asemptomatik

High Prevalence of SARS-COV-2 infection in patients undergoing cataract surgery

Öz

Objective
The coronavirus disease 2019 (COVID-19) prevalence has rapidly been increased worldwide in the last a few months. Asymptomatic COVID-19 cases scheduled for elective surgeries can be a risk factor for the healthcare professionals. The aim of this study was to estimate the prevalence of SARS-CoV-2 infection in patients undergoing cataract surgery.
Methods
Patients scheduled for cataract surgery in months of November and December 2020 were included in the study. COVID 19 PCR (polymerase chain reaction) test was taken routinely from all patients within 48 hours before the operation date.
Result
In this study, 151 patients who planned cataract surgery were included. The average age of the patients was 64,6±12,6 years. The study population consisted of 94 (%62,3)men and 57 (%37,7) women. According to COVID 19 PCR test results, there were 16 (%10.6) positive cases. All cases were asymptomatic.
Conclusions
Asymptomatic covid patients continue to be contagious. We need to be careful when taking elective cases to minimize the risk of adverse outcomes after surgery and transmission of viruses to medical staff and other patients.

Anahtar Kelimeler

COVID-19, Ophthalmology, Cataract surgery, SARS-CoV2, Asymptomatic

Kaynakça

• 1. World Health Organization (WHO). COVID-19 Weekly Epidemiological Update. [İnternet] 2020. Link:https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
• 2. Greenland JR, Michelow MD, Wang L, London MJ. COVID-19 infection: implications for perioperative and critical care physicians. Anesthesiology. 2020;132(6):1346-1361.
• 3. Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382(12):1177-1179.
• 4. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou C, He X, et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708-1720.
• 5. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
• 6. Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020;323(14):1406-1407.
• 7. Gudbjartsson DF, Helgason A, Jonsson H, Magnusson OT, Melsted P, Norddahle GL, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med. 2020;382:2302-2315.
• 8. To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis. 2020;20:565-74.
• 9. To K, Yip C, Lai C, Wong C, Ho D, Pang P, et al. Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study. Clin Microbiol Infect. 2019;25:372-8.
• 10. Guo ZD, Wang ZY, Zhang SF, Li X, Li L, Li C, et al. Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7): 1583-1591.
• 11. Backer Jantien A, Klinkenberg Don, Wallinga Jacco. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China. Euro Surveill. 2020;25(5):2000062
• 12. Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung SM et al. Incubation period and other epidemiological characteristics of, 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020;9(2):538.
• 13. Liu Y, Yan LM, Wan L, Xiang T, Le A, Liu JM, et al. Viral Dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-657.
• 14. Xu K, Chen Y, Yuan J, Yi P, Ding C, Wu W, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clin Infect Dis. 2020;71(15):799-806.
• 15. Ji Y, Ma Z, Peppelenbosch MP, Pan Q. Potential association between COVID-19 mortality and health-care resource availability. The Lancet Global Health. 2020;8(4): e480.
• 16. American Academy of Ophthalmology. Important coronavirus updates for ophthalmologists. [İnternet] 2020. Link: https://www.aao.org/headline/alert importantcoronavirus-context.
• 17. RCOphth: management of ophthalmology services during the Covid pandemic. Royal College of Ophthalmologists. [İnternet] 2020. Link:https://www.rcophth.ac.uk/wp-content/uploads/2020/03/RCOphth-Management-of-Ophthalmology-Services-during-the-Covid-pandemic-280320.pdf
• 18. ACS COVID-19: Recommendations for Management of Elective Surgical Procedures. [İnternet] 2020. Link: https://facs.org/covid-19/clinical-guidance/elective-case/cancer-surgery.
• 19. Nahshon C, Bitterman A, Haddad R, Hazzan D, Lavie O. Hazardous postoperative outcomes of unexpected COVID-19 infected patients: a call for global consideration of sampling all asymptomatic patients before surgical treatment. World J Surg. 2020;44:2477-2481.
• 20. Spinelli A, Pellino G. COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg. 2020;107(7):785-787.
• 21. Szegedi S, Huf W, Miháltz K, Vécsei-Marlovits PV. Prevalence of SARS-CoV-2 infection in patients presenting for intravitreal injection. Spektrum Augenheilkd. 2020;11:1-5.
• 22. Aytogan H, Ayintap E, Özkalay Yilmaz N. Detection of corona¬virus disease 2019 viral material on environmental surfaces of an ophthalmology examination room. JAMA Ophthalmol. 2020;138(9):990–993